211 related articles for article (PubMed ID: 23339869)
1. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
3. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
4. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
Lin VT; Lin FT
Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
6. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT
Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301
[TBL] [Abstract][Full Text] [Related]
7. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27
Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z
Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533
[TBL] [Abstract][Full Text] [Related]
8. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells.
Wang Q; Zhou Y; Wang X; Evers BM
Cell Death Differ; 2008 May; 15(5):908-19. PubMed ID: 18408738
[TBL] [Abstract][Full Text] [Related]
9. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
10. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.
Ho WC; Pikor L; Gao Y; Elliott BE; Greer PA
J Biol Chem; 2012 May; 287(19):15458-65. PubMed ID: 22427650
[TBL] [Abstract][Full Text] [Related]
11. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
13. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL
Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017
[TBL] [Abstract][Full Text] [Related]
14. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
[TBL] [Abstract][Full Text] [Related]
16. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
17. Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization.
Lv K; Chen L; Li Y; Li Z; Zheng P; Liu Y; Chen J; Teng J
J Neurosci; 2015 Feb; 35(6):2559-71. PubMed ID: 25673849
[TBL] [Abstract][Full Text] [Related]
18. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
19. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.
Lai YJ; Chen CS; Lin WC; Lin FT
Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells.
Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC
J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]